Showing 181 - 200 results of 693 for search '"Parkinson's disease"', query time: 0.07s Refine Results
  1. 181
  2. 182
  3. 183
  4. 184

    Tamsulosin use in benign prostatic hyperplasia and risks of Parkinson's disease, Alzheimer's disease and mortality: An observational cohort study of elderly Medicare enrollees. by Kin Wah Fung, Fitsum Baye, Seo H Baik, Clement J McDonald

    Published 2024-01-01
    “…For mortality, alfuzosin was associated with 27% risk reduction (HR 0.73, 95%CI 0.68-0.78), and doxazosin with 6% risk reduction (HR 0.94, 95%CI 0.91-0.97). For Parkinson's disease, terazosin was associated with 26% risk reduction (HR 0.74, 95%CI 0.66-0.83), and doxazosin with 21% risk reduction (HR 0.79, 95%CI 0.72-0.88). …”
    Get full text
    Article
  5. 185
  6. 186

    miR-16-1 Promotes the Aberrant α-Synuclein Accumulation in Parkinson Disease via Targeting Heat Shock Protein 70 by Zhelin Zhang, Yan Cheng

    Published 2014-01-01
    “…There is striking evidence that heat shock protein 70 (Hsp70) negatively regulates α-synuclein aggregation, which plays a significant role in the formation and progression of Parkinson disease (PD). However, how the Hsp70 in neurons fails to prevent or even reverse α-synuclein aggregation and toxicity in PD still remains to be determined. …”
    Get full text
    Article
  7. 187
  8. 188
  9. 189
  10. 190
  11. 191
  12. 192

    Wearable devices may aid the recognition of fluctuation-related pain in Parkinson's disease-An exploratory, cross-sectional analysis of two prospective observational studies. by Katarina Rukavina, Juliet Staunton, Pavlos Zinzalias, Magdalena Krbot Skoric, Kit Wu, Kirsty Bannister, Alexandra Rizos, K Ray Chaudhuri

    Published 2025-01-01
    “…Fluctuation-related pain (FRP) affects more than one third of people with Parkinson's disease (PwP, PD) and has a harmful effect on health-related quality of life (HRQoL), but often remains under-reported by patients and neglected by clinicians. …”
    Get full text
    Article
  13. 193
  14. 194
  15. 195

    In Vivo Visualization and Monitoring of Viable Neural Stem Cells Using Noninvasive Bioluminescence Imaging in the 6-Hydroxydopamine-Induced Mouse Model of Parkinson Disease by Hyung-Jun Im, Do Won Hwang, Han Kyu Lee, Jaeho Jang, Song Lee, Hyewon Youn, Yeona Jin, Seung U. Kim, E. Edmund Kim, Yong Sik Kim, Dong Soo Lee

    Published 2013-06-01
    “…Transplantation of neural stem cells (NSCs) has been proposed as a treatment for Parkinson disease (PD). The aim of this study was to monitor the viability of transplanted NSCs expressing the enhanced luciferase gene in a mouse model of PD in vivo. …”
    Get full text
    Article
  16. 196
  17. 197
  18. 198

    Assessment of temporospatial and kinematic gait parameters using human pose estimation in patients with Parkinson's disease: A comparison between near-frontal and lateral views. by Jeongsik Kim, Ryul Kim, Kyeongho Byun, Nyeonju Kang, Kiwon Park

    Published 2025-01-01
    “…Gait disturbance is one of the most common symptoms in patients with Parkinson's disease (PD) that is closely associated with poor clinical outcomes. …”
    Get full text
    Article
  19. 199
  20. 200